Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, +45

New England Journal of Medicine

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani, +22

Blood

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi, +42

Journal of Clinical Oncology

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, +21

Blood

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti, +22

Blood

Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab

Antonio M. Risitano, Rosario Notaro, Ludovica Marando, +18

Blood

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Renato Bassan, Giuseppe Rossi, Enrico Maria Pogliani, +17

Journal of Clinical Oncology

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

Giuseppe Avvisati, Francesco Lo‐Coco, Francesca Paoloni, +22

Blood

Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin's Lymphoma in Adults

Donato Gemmati, Alessia Ongaro, Gian L. Scapoli, +11

Cancer Epidemiology Biomarkers & Prevention

Methylation PathwayCancer PathologyMixed-phenotype Acute LeukemiaGeneticsGenetic Epidemiology +16

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies

Wilma Barcellini, Francesco Zaja, Anna Zaninoni, +8

Blood